Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax...

  • Main
  • 2017 / 01
  • Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax...
Annals of Oncology 2017 / 01

Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients

Mato, A.R., Hill, B.T., Lamanna, N., Barr, P.M., Ujjani, C.S., Brander, D.M., Howlett, C., Skarbnik, A.P, Cheson, B.D., Zent, C.S., Pu, J.J., Kiselev, P., Foon, K., Lenhart, J., Henick Bachow, S., Win
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx031
Date:
January, 2017
File:
PDF, 240 KB
english, 2017
Conversion to is in progress
Conversion to is failed